SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a
SHANGHAI,Jan. 10,2025--JW Therapeutics (HKEx: 2126),an independentandinnovative biotechnology company focused on developing,manufacturing and commercializing cell immunotherapy products,announced that
